Midostaurin

• Status: DMF No.: 026257 • Usage: For Entecavir

• Status: DMF No.: 028552 • Usage: For Fondaparinux Sodium

• Status: Pilot • Patent Expiration: Off-patent • Usage: Progestogens

• Status: Pre-validation • Patent Expiration: Off-patent • Usage: Anti-infection

• Status: DMF No.: 030090 • Patent Expiration: Off-patent • Usage: Immunosuppressant

• Status: MF No.: 230MF10023 • Patent Expiration: Off-patent • Usage: Oncology

• Status: DMF No. :030767 • Patent Expiration: Off-patent • Usage:Anticoagulant

Status:
DMF No.: 032010                                              
ASMF Approved
Patent Expiration: Off-patentUsage: Antifungal

• Status: MF No.: 230MF10028; USDMF to be filed in Q4,2020 • Patent Expiration: Off-patent • Usage:Anticoagulant

• Status: ASMF Approved & DMF No.:034091 • Patent Expiration:Off-patent • Usage:Antifungal

Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes entecavir monohydrate. It belongs to anti-viral category. Contact us for more information. • Status: DMF No.:031949 • Patent Expiration: Off-patent • Usage:AntiHBV

• Status: Validated • Patent Expiration: US：2023.07.20 ；CN：off-patent • Usage: Oncology